Summary
This prediction ended on 28.12.15 with a price of €116.10. The price of Bayer AG has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -12.01%. exploration has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | -3.100% | -3.100% | 80.976% | -27.973% |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% | 70.406% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% | 103.787% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% | 45.417% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% | 64.908% |
Comments by exploration for this prediction
In the thread Bayer AG diskutieren
Bayer: langfristig positiv
Bayer ist für langfristig orientierte Anleger ein Basisinvestment. Somit können Rückschläge bis 130€ für Käufe getätigt werden. Unter 122€ wird es kritisch.
(Laufzeit überschritten)